[Plasmodium vivax infection: not so benign].

Area of Science:

• Malariology
• Infectious Diseases
• Tropical Medicine

Context:

• Plasmodium falciparum is the primary cause of malaria morbidity and mortality globally.
• Plasmodium vivax is increasingly recognized as a significant cause of severe malaria outside of Africa.
• Severe manifestations like cerebral malaria, respiratory distress, and anemia are reported, often affecting younger populations.

Purpose:

• To highlight the underappreciated severity of Plasmodium vivax malaria.
• To alert clinicians to the potential for severe disease caused by Plasmodium vivax.
• To stimulate research into the pathogenic mechanisms of Plasmodium vivax.

Summary:

• While Plasmodium falciparum dominates malaria mortality, Plasmodium vivax is now understood to cause severe disease and death in many regions.
• Severe Plasmodium vivax malaria presents with complications such as cerebral malaria, severe anemia, and respiratory distress, particularly in younger individuals.
• The mechanisms underlying Plasmodium vivax-induced severe disease remain unclear, as infected erythrocyte sequestration, a hallmark of P. falciparum, is not typically observed.

Impact:

• Raises awareness among healthcare providers about the potential severity of Plasmodium vivax infections.
• Underscores the need for improved diagnostics and treatment strategies for Plasmodium vivax malaria.
• Stimulates further investigation into the pathogenesis of severe Plasmodium vivax malaria to inform public health interventions.